Canada Life’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.67M | Buy |
22,135
+1,241
| +6% | +$97.9K | ﹤0.01% | 1206 |
|
|
2025
Q4 | $1.65M | Sell |
20,894
-25,234
| -55% | -$1.9M | ﹤0.01% | 1219 |
|
|
2025
Q3 | $2.96M | Sell |
46,128
-373
| -0.8% | -$18.2K | ﹤0.01% | 1060 |
|
|
2025
Q2 | $1.84M | Buy |
46,501
+2,648
| +6% | +$86.7K | ﹤0.01% | 1222 |
|
|
2025
Q1 | $1.33M | Buy |
43,853
+4,639
| +12% | +$152K | ﹤0.01% | 1341 |
|
|
2024
Q4 | $1.37M | Sell |
39,214
-621
| -2% | -$23.2K | ﹤0.01% | 1389 |
|
|
2024
Q3 | $1.6M | Sell |
39,835
-5,713
| -13% | -$266K | ﹤0.01% | 1373 |
|
|
2024
Q2 | $2.17M | Buy |
45,548
+3,668
| +9% | +$150K | ﹤0.01% | 1252 |
|
|
2024
Q1 | $1.82M | Buy |
41,880
+1,099
| +3% | +$52.4K | ﹤0.01% | 1295 |
|
|
2023
Q4 | $2.05M | Buy |
40,781
+3,980
| +11% | +$191K | ﹤0.01% | 1234 |
|
|
2023
Q3 | $1.67M | Buy |
36,801
+8,758
| +31% | +$361K | ﹤0.01% | 1301 |
|
|
2023
Q2 | $1.16M | Buy |
28,043
+621
| +2% | +$23.9K | ﹤0.01% | 1449 |
|
|
2023
Q1 | $983K | Buy |
27,422
+1,282
| +5% | +$48.1K | ﹤0.01% | 1509 |
|
|
2022
Q4 | $993K | Buy |
26,140
+9,005
| +53% | +$379K | ﹤0.01% | 1527 |
|
|
2022
Q3 | $757K | Buy |
17,135
+10,415
| +155% | +$439K | ﹤0.01% | 1580 |
|
|
2022
Q2 | $248K | Buy |
6,720
+115
| +2% | +$4.34K | ﹤0.01% | 1791 |
|
|
2022
Q1 | $260K | Sell |
6,605
-438
| -6% | -$14.3K | ﹤0.01% | 1834 |
|
|
2021
Q4 | $214K | Buy |
7,043
+121
| +2% | +$3.81K | ﹤0.01% | 1860 |
|
|
2021
Q3 | $234K | Sell |
6,922
-26,244
| -79% | -$989K | ﹤0.01% | 1879 |
|
|
2021
Q2 | $1.32M | Sell |
33,166
-24,310
| -42% | -$952K | ﹤0.01% | 1378 |
|
|
2021
Q1 | $2.57M | Sell |
57,476
-3,037
| -5% | -$169K | 0.01% | 977 |
|
|
2020
Q4 | $3.42M | Buy |
60,513
+8,416
| +16% | +$419K | 0.01% | 883 |
|
|
2020
Q3 | $2.47M | Buy |
52,097
+2,113
| +4% | +$117K | 0.01% | 961 |
|
|
2020
Q2 | $2.94M | Buy |
49,984
+16,840
| +51% | +$937K | 0.01% | 892 |
|
|
2020
Q1 | $1.58M | Buy |
33,144
+180
| +0.5% | +$10K | ﹤0.01% | 1070 |
|
|
2019
Q4 | $1.98M | Buy |
+32,964
| New | +$1.96M | ﹤0.01% | 1143 |
|
|
2019
Q3 | – | Sell |
-30,172
| Closed | -$1.94M | – | 1684 |
|
|
2019
Q2 | $1.94M | Buy |
30,172
+12,459
| +70% | +$881K | ﹤0.01% | 1202 |
|
|
2019
Q1 | $1.43M | Buy |
17,713
+2,450
| +16% | +$158K | ﹤0.01% | 1238 |
|
|
2018
Q4 | $796K | Buy |
15,263
+1,535
| +11% | +$78.3K | ﹤0.01% | 1496 |
|
|
2018
Q3 | $709K | Hold |
13,728
| – | – | ﹤0.01% | 1639 |
|
|
2018
Q2 | $572K | Sell |
13,728
-1,375
| -9% | -$61K | ﹤0.01% | 1707 |
|
|
2018
Q1 | $667K | Hold |
15,103
| – | – | ﹤0.01% | 1641 |
|
|
2017
Q4 | $758K | Buy |
15,103
+1,807
| +14% | +$99.1K | ﹤0.01% | 1617 |
|
|
2017
Q3 | $698K | Buy |
13,296
+1,096
| +9% | +$57.4K | ﹤0.01% | 1637 |
|
|
2017
Q2 | $620K | Hold |
12,200
| – | – | ﹤0.01% | 1661 |
|
|
2017
Q1 | $489K | Hold |
12,200
| – | – | ﹤0.01% | 1709 |
|
|
2016
Q4 | $586K | Sell |
12,200
-1,800
| -13% | -$71.2K | ﹤0.01% | 1657 |
|
|
2016
Q3 | $512K | Sell |
14,000
-17,425
| -55% | -$545K | ﹤0.01% | 1656 |
|
|
2016
Q2 | $731K | Hold |
31,425
| – | – | ﹤0.01% | 1534 |
|
|
2016
Q1 | $1.27M | Buy |
31,425
+7,090
| +29% | +$288K | ﹤0.01% | 792 |
|
|
2015
Q4 | $1.51M | Buy |
24,335
+1,622
| +7% | +$87.5K | 0.01% | 771 |
|
|
2015
Q3 | $919K | Buy |
22,713
+4,130
| +22% | +$214K | ﹤0.01% | 824 |
|
|
2015
Q2 | $1.07M | Hold |
18,583
| – | – | ﹤0.01% | 909 |
|
|
2015
Q1 | $1.18M | Buy |
18,583
+8,275
| +80% | +$561K | ﹤0.01% | 891 |
|
|
2014
Q4 | $635K | Hold |
10,308
| – | – | ﹤0.01% | 937 |
|
|
2014
Q3 | $402K | Buy |
10,308
+2,091
| +25% | +$74.1K | ﹤0.01% | 982 |
|
|
2014
Q2 | $282K | Hold |
8,217
| – | – | ﹤0.01% | 997 |
|
|
2014
Q1 | $353K | Hold |
8,217
| – | – | ﹤0.01% | 945 |
|
|
2013
Q4 | $329K | Buy |
+8,217
| New | +$293K | ﹤0.01% | 946 |
|
Other funds holding IONS
VPM
VCM
Canada Life's IONS Position: Q1 2026 in Review
Canada Life increased its Ionis Pharmaceuticals (IONS) stake by 5.9% in Q1 2026, buying an estimated $97.9K and bringing the position to 22,135 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1206.
Canada Life first reported a position in IONS in Q4 2013 and has held it in 49 quarters since. The position peaked at $3.42M in Q4 2020. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Canada Life held 22,135 shares of Ionis Pharmaceuticals worth $1.67M as of Q1 2026.
- Canada Life bought 1,241 Ionis Pharmaceuticals shares in Q1 2026, an estimated $97.9K.
- Ionis Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1206 holding.
- Canada Life first reported a position in Ionis Pharmaceuticals in Q4 2013 and has held it in 49 quarters since.
- Canada Life's Ionis Pharmaceuticals position peaked at $3.42M in Q4 2020.
- 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.